Article
Strong HCV NS3- and NS4A-specific cellular immune responses induced in mice and Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
Vaccine - 18 Nov 2008
Lang Krystle A, Yan Jian, Draghia-Akli Ruxandra, Khan Amir, Weiner David B
Abstract excerpt
Hepatitis C virus (HCV) represents a major health burden with more than 170 million individuals currently infected worldwide, equaling roughly 3% of the world's population. HCV preferentially infects hepatocytes and is able to persist in up to 70% of infected individuals. It is estimated that up to 30% of chronically infected individuals will go on to develop progressive liver disease as a result of HCV...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
